title: Reduced Na(+)-K+ pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibition.
abstract: This study addresses the question of whether a decrease in basal Na+ pump [Na(+)-K(+)-adenosinetriphosphatase (ATPase)] activity occurs in the carotid artery of an alloxan-diabetic rabbit and, if so, whether it is associated with altered 86Rb+ uptake and contractile response to ouabain and K(+)-free solution. Ouabain-sensitive 86Rb+ uptake, an index of Na+ pump activity, was diminished approximately 50% in carotid arteries from diabetic rabbits. Concurrent with this, contractions induced by incubating the carotid arteries in a K(+)-free solution (in the absence of phentolamine) were significantly larger in the diabetic group. Readdition of K+ (1 mM) to arteries contracted with the K(+)-free solution caused relaxations that were slower to occur and of lesser magnitude in diabetic than in control rabbits. In contrast to the contractions caused by the K(+)-free medium, contractions caused by incubation with ouabain (1 mM) in the presence of phentolamine were significantly smaller in the diabetic group. Treatment of diabetic rabbits with an aldose reductase inhibitor, zopolrestat, at both high and low doses restored the alterations in vascular reactivity toward normal. The results indicate that the Na+ pump activity is diminished in the carotid artery of diabetic rabbit, and this is associated with abnormal vascular responsiveness and increased polyol pathway flux.
authors.affiliation: Robert Dawson Evans Department of Clinical Research, Boston University School of Medicine, Massachusetts 02118.
authors.forename: B
authors.initials: B
authors.lastname: Tesfamariam
authors.forename: S
authors.initials: S
authors.lastname: Gupta
authors.forename: P J
authors.initials: PJ
authors.lastname: Oates
authors.forename: N B
authors.initials: NB
authors.lastname: Ruderman
authors.forename: R A
authors.initials: RA
authors.lastname: Cohen
mesh_terms: D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D052160:Benzothiazoles; D002339:Carotid Arteries / Q000378:metabolism*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D010793:Phthalazines / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011817:Rabbits; D012413:Rubidium / Q000493:pharmacokinetics; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013844:Thiazoles / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
chemical_list: D052160:Benzothiazoles; D010793:Phthalazines; D013844:Thiazoles; C067172:zopolrestat; D010042:Ouabain; D000449:Aldehyde Reductase; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium; D011188:Potassium